Moore Capital Management »

Oric Pharmaceuticals shares owned by Moore Capital Management

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $755k 60k 12.67

More positions owned by Moore Capital Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ally Financial (ALLY)
Bank of America Corporation (BAC)
Ubs Group SHS (UBS)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Apollo Global Mgmt (APO)
Coinbase Global Note 0.500% 6/0 (Principal)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Etsy Note 0.125%10/0 (Principal)
Global Payments (GPN)
Fidelity National Information Services (FIS)

View all positions for Moore Capital Management

Top funds holding Oric Pharmaceuticals

Nextech Invest
EcoR1 Capital
BlackRock
Viking Global Investors
Pfizer
Vanguard Group
Sr One Capital Management
Alkeon Capital Management
VR Adviser
State Street Corporation
NEA Management Company
Vanguard Capital Management
Column Group
OrbiMed Advisors
FMR

View all funds holding Oric Pharmaceuticals